1077 |
The COGENT Trial |
|
Mar. 15. 10 |
1076 |
FFR vs. Angiography for Multivessel Evaluation: FAME - 2 Year Follow-Up |
|
Mar. 15. 10 |
1075 |
LEADERS: A Prospective, Randomised, Non-Inferiority Trial Comparing Biolimus-Eluting Stent With Biodegradable Polymer Versus Sirolimus-Eluting Stent With Durable Polymer - 2-Year Clinical Follow-Up |
|
Mar. 15. 10 |
1074 |
SIRTAX-LATE: 5-Year Clinical and Angiographic Follow-up From a Prospective, Randomized Trial Comparing Sirolimus-Eluting With Paclitaxel-Eluting Stents |
|
Mar. 15. 10 |
1073 |
Prospective, Randomized Trial of Paclitaxel- versus Sirolimus-Eluting Stents for Treatment of Coronary Restenosis in Sirolimus-Eluting Stents |
|
Mar. 15. 10 |
1072 |
Compare Trial |
|
Mar. 15. 10 |
1071 |
SPIRIT IV: A Prospective, Randomized Trial Comparing an Everolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease - One Year Clinical Results |
|
Mar. 15. 10 |
1070 |
How & Why CTO?_Passion, Confidence, Success and Happiness |
Seung-Whan Lee |
Jan. 11. 10 |
1069 |
DECISION CTO_New Horizon in CTO Treatment; Randomized Study Proposal |
Seung-Jung Park |
Jan. 11. 10 |
1068 |
Update on Coronary Angioscopy |
Yasunori Ueda |
Dec. 16. 09 |